Pressure Bio Raises $826K in Private Placement, Gets Nasdaq Warning Letter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has raised $825,720 in gross proceeds from a private placement, it said in a document filed on Tuesday with the US Securities and Exchange Commission.

The South Easton, Mass.-based company also disclosed that it has received a letter from Nasdaq saying its stock fails to meet a listing requirement and could face delisting action.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.